Raysearch Laboratories Ab Stock Analysis
| RSLBF Stock | USD 23.00 0.00 0.00% |
RaySearch Laboratories holds a debt-to-equity ratio of 0.802. RaySearch Laboratories' financial risk is the risk to RaySearch Laboratories stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
RaySearch Laboratories' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. RaySearch Laboratories' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps RaySearch Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect RaySearch Laboratories' stakeholders.
For many companies, including RaySearch Laboratories, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for RaySearch Laboratories AB, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, RaySearch Laboratories' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that RaySearch Laboratories' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which RaySearch Laboratories is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of RaySearch Laboratories to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, RaySearch Laboratories is said to be less leveraged. If creditors hold a majority of RaySearch Laboratories' assets, the Company is said to be highly leveraged.
RaySearch Laboratories AB is undervalued with Real Value of 24.15 and Hype Value of 23.0. The main objective of RaySearch Laboratories pink sheet analysis is to determine its intrinsic value, which is an estimate of what RaySearch Laboratories AB is worth, separate from its market price. There are two main types of RaySearch Laboratories' stock analysis: fundamental analysis and technical analysis.
The RaySearch Laboratories pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and RaySearch Laboratories' ongoing operational relationships across important fundamental and technical indicators.
RaySearch |
RaySearch Pink Sheet Analysis Notes
About 56.0% of the company shares are owned by institutional investors. The book value of RaySearch Laboratories was at this time reported as 2.05. The company last dividend was issued on the 18th of May 2016. RaySearch Laboratories had 3:1 split on the 25th of June 2008. RaySearch Laboratories AB , a medical technology company, develops software solutions for cancer treatment worldwide. RaySearch Laboratories AB is headquartered in Stockholm, Sweden. Raysearch Laboratories operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 389 people.The quote for RaySearch Laboratories AB is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about RaySearch Laboratories AB contact Johan Lof at 46 8 51 05 30 00 or learn more at https://www.raysearchlabs.com.RaySearch Laboratories Investment Alerts
| RaySearch Laboratories generated a negative expected return over the last 90 days | |
| The company reported the revenue of 641.67 M. Net Loss for the year was (47.31 M) with profit before overhead, payroll, taxes, and interest of 591.28 M. | |
| About 56.0% of the company shares are owned by institutional investors |
RaySearch Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 192.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RaySearch Laboratories's market, we take the total number of its shares issued and multiply it by RaySearch Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.RaySearch Profitablity
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.Technical Drivers
As of the 13th of February 2026, RaySearch Laboratories holds the Coefficient Of Variation of (484.60), risk adjusted performance of (0.16), and Variance of 1.68. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of RaySearch Laboratories, as well as the relationship between them. Please check RaySearch Laboratories standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if RaySearch Laboratories is priced some-what accurately, providing market reflects its current price of 23.0 per share. Given that RaySearch Laboratories has variance of 1.68, we recommend you to check out RaySearch Laboratories's recent market performance to make sure the company can sustain itself at a future point.RaySearch Laboratories Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in RaySearch Laboratories price series with the more recent values given greater weights.
RaySearch Laboratories Predictive Daily Indicators
RaySearch Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of RaySearch Laboratories pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
RaySearch Laboratories Forecast Models
RaySearch Laboratories' time-series forecasting models are one of many RaySearch Laboratories' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary RaySearch Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.RaySearch Laboratories Debt to Cash Allocation
Many companies such as RaySearch Laboratories, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
RaySearch Laboratories AB has accumulated 13.74 M in total debt with debt to equity ratio (D/E) of 0.8, which is about average as compared to similar companies. RaySearch Laboratories has a current ratio of 1.11, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist RaySearch Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, RaySearch Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RaySearch Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RaySearch to invest in growth at high rates of return. When we think about RaySearch Laboratories' use of debt, we should always consider it together with cash and equity.RaySearch Laboratories Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the RaySearch Laboratories' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of RaySearch Laboratories, which in turn will lower the firm's financial flexibility.About RaySearch Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how RaySearch Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling RaySearch shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as RaySearch Laboratories. By using and applying RaySearch Pink Sheet analysis, traders can create a robust methodology for identifying RaySearch entry and exit points for their positions.
RaySearch Laboratories AB , a medical technology company, develops software solutions for cancer treatment worldwide. RaySearch Laboratories AB is headquartered in Stockholm, Sweden. Raysearch Laboratories operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 389 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding RaySearch Laboratories to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Complementary Tools for RaySearch Pink Sheet analysis
When running RaySearch Laboratories' price analysis, check to measure RaySearch Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RaySearch Laboratories is operating at the current time. Most of RaySearch Laboratories' value examination focuses on studying past and present price action to predict the probability of RaySearch Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RaySearch Laboratories' price. Additionally, you may evaluate how the addition of RaySearch Laboratories to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |